Targeted Sustained-Release Therapy for Vulnerable Atherosclerotic Plaques Using Luteolin-Loaded Nanoparticles
This work provides a robust and translationally promising nanoplatform for the precision treatment of VAPs, offering a novel strategy for safe and effective intervention in atherosclerotic cardiovascular disease.
Authors
- Shaoshen Wang (ORCID: https://orcid.org/0000-0003-3898-9558)
- Tongda Xu (ORCID: https://orcid.org/0000-0002-5594-3992)
- Wei Qian (ORCID: https://orcid.org/0000-0002-8946-8587)
- Jie Huang (ORCID: https://orcid.org/0000-0002-3917-912X)
- Chaofan Wang (ORCID: https://orcid.org/0000-0001-6700-8654)
- Xianbiao Shi
- Dongye Li (ORCID: https://orcid.org/0000-0001-5272-1473)
- Yetong Wu
- Yanru Wang (ORCID: https://orcid.org/0000-0001-8272-2450)
- Xiaxia Li
- Yang Liu
- Xiaoqi Li
Institutions
- Xuzhou Medical College (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/ijn.s566896
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00